← Back to Search

NIATx Coaching for HIV, Hepatitis C, and Opioid Use Disorder Management (BIRCH Trial)

N/A

Recruiting

Led By Frederick L Altice, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up every 6 months for 24 months

Awards & highlights

BIRCH Trial Summary

This trial will evaluate an intervention to introduce screening, evaluation and treatment of HIV/hep C/opioid use disorder in WV primary care clinics to improve health outcomes.

Who is the study for?

This trial is for Federally Qualified Health Centers and similar primary care clinics in West Virginia that provide adult care. It's not open to private or specialty clinics, or any clinic outside of West Virginia.Check my eligibility

What is being tested?

The study tests a strategy called NIATx Coaching to integrate screening, evaluation, and treatment procedures for HIV, hepatitis C, and Opioid Use Disorder into primary care. Clinics will receive training and coaching to adopt these practices.See study design

What are the potential side effects?

Since this trial focuses on integrating treatment strategies rather than testing new medications, it does not directly involve medication side effects. However, the process may uncover challenges in managing patients' conditions.

BIRCH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ every 6 months for 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~every 6 months for 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and every 6 months for 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Integration of services

Number of patients initiated on antiretroviral medication (ART) for HIV

Number of patients initiated on medication for HCV

+6 more

Secondary outcome measures

Number of patients on PrEP to prevent HIV

Number of patients retained on medication (ART) for HIV

Number of patients retained on medication for OUD for at least 6 months

+3 more

BIRCH Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention - Nominal Group Technique, Training, CoachingExperimental Treatment1 Intervention

Each group of clinics will receive the same intervention in a step-wedge design, starting every 6-months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,737,648 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,465 Previous Clinical Trials

2,618,613 Total Patients Enrolled

West Virginia UniversityOTHER

175 Previous Clinical Trials

56,286 Total Patients Enrolled

Media Library

Intervention - Nominal Group Technique, Training, Coaching Clinical Trial Eligibility Overview. Trial Name: NCT05668780 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Intervention - Nominal Group Technique, Training, Coaching

Human Immunodeficiency Virus Infection Clinical Trial 2023: Intervention - Nominal Group Technique, Training, Coaching Highlights & Side Effects. Trial Name: NCT05668780 — N/A

Intervention - Nominal Group Technique, Training, Coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT05668780 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being accepted for this exploration?

"Clinicaltrials.gov reveals that this trial is still open for participant recruitment, which began on January 24th 2023 and was updated as recently as March 1st 2023."

Answered by AI

How many patients are being inducted into this investigation?

"Affirmative. Clinicaltrials.gov displays that this clinical trial is actively recruiting participants, which was initially launched on January 24th 2023 and last modified on March 1st 2023. The study seeks to recruit a total of twenty patients from one medical site."

Answered by AI

What is the ultimate aim of this experiment?

"The aim of this two year trial, which will be assessed every 6 months, is to successfully integrate these services. Secondary objectives include tracking the number of patients retained on medication for opioid use disorder (OUD) and HIV, as well as monitoring viral suppression levels in those living with HIV at 6 and 12 month intervals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Buprenorphine Integration Research and Community Health

2023. "Buprenorphine Integration Research and Community Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05668780.

All > Hepatitis C